| 2025 |
Sawan, M. J., Clough, A. J., Hillen, J., Zullo, A. R., Moga, D. C., Soulsby, N., & Gnjidic, D. (2025). Variation in the potentially inappropriate use of antipsychotic and benzodiazepine medications among individuals receiving residential medication management reviews. International Journal Of Pharmacy Practice, 33(3), 332-339.
DOI |
| 2025 |
Wiblin, S., Lai, Y., Soulsby, N., & Hillen, J. (2025). Vaccination in aged care in Australia: a retrospective study of influenza, herpes zoster, and pneumococcal vaccination. Vaccines, 13(7, article no. 766), 1-12.
DOI |
| 2025 |
de Haart, K., Asao, K., Ataher, Q., Geier, J., Hillen, J., Huang, K., . . . Bloem, L. T. (2025). Long-term follow-up after authorization of gene therapy: leveraging real-world data. Drug Discovery Today, 30(5, article no. 104337), 1-11.
DOI Scopus10 WoS10 Europe PMC6 |
| 2025 |
Gutteridge, D. S., Calder, A. H., Stasinopoulos, J., Javanparast, S., Caughey, G. E., Hillen, J. B., . . . Sluggett, J. K. (2025). Quality indicators for safe and effective use of medications in long-term care settings: A systematic review. British Journal of Clinical Pharmacology, 91(11), 3054-3069.
DOI Europe PMC1 |
| 2025 |
Ho, J. N., Hillen, J. B., Daniels, B., Lim, R., & Pratt, N. (2025). Systematic Evaluation of Australian Risk Management Plans for Biologic Medicines. Drug Safety, 48(9), 1063-1072.
DOI |
| 2025 |
Hillen, J. B., Stanford, T., Ward, M., Duszynski, K., Tong, X., Li, S. X., . . . Pratt, N. (2025). Medicines Policy in Action: The Impact on Volume and Cost of Biologic Medicines After Biosimilar Introduction. Value in Health Regional Issues, 50(101173), 7 pages.
DOI |
| 2024 |
Sluggett, J. K., Stasinopoulos, J., Sylvester, C., Wong, W. J., Hillen, J., Hughes, G. A., . . . Soulsby, N. (2024). Simplifying medication regimens for residents of aged care facilities: Pharmacist and physician use of a structured five-step medication simplification tool. Research in Social and Administrative Pharmacy, 20(8), 733-739.
DOI Scopus1 WoS1 Europe PMC1 |
| 2024 |
Sawan, M. J., Clough, A., Hillen, J., Soulsby, N., & Gnjidic, D. (2024). Comparison of polypharmacy and potentially inappropriate medication use in older adults with and without dementia receiving residential medication management reviews. Australasian Journal on Ageing, 43(3), 628-635.
DOI |
| 2023 |
Peng, K., Blais, J. E., Pratt, N. L., Guo, J. J., Hillen, J. B., Stanford, T., . . . Li, X. (2023). Impact of introducing infliximab biosimilars on total infliximab consumption and originator infliximab prices in eight regions: an interrupted time-series analysis. BioDrugs, 37(3), 409-420.
DOI Scopus10 WoS11 Europe PMC6 |
| 2022 |
Seo, M. S., Hillen, J., Kang, D. Y., Pratt, N., & Shin, J. Y. (2022). Prescription Patterns of Asthma Preventers Among Children and Adolescents Between Australia and South Korea. Frontiers in Pharmacology, 13(834116), 8 pages.
DOI Scopus4 WoS3 Europe PMC2 |
| 2022 |
Hillen, J. B., Stanford, T., Ward, M., Roughead, E. E., Kalisch-Ellett, L., & Pratt, N. (2022). Rituximab and Pyoderma Gangrenosum: An Investigation of Disproportionality Using a Systems Biology-Informed Approach in the FAERS Database. Drugs Real World Outcomes, 9(4), 639-647.
DOI Scopus3 WoS2 Europe PMC3 |
| 2022 |
Tong, X., Li, X., Pratt, N. L., Hillen, J. B., Stanford, T., Ward, M., . . . Wong, I. C. K. (2022). Monoclonal antibodies and Fc-fusion protein biologic medicines: a multinational cross-sectional investigation of accessibility and affordability in Asia Pacific regions between 2010 and 2020. Lancet Regional Health-Western Pacific, 26(100506), 1-12.
DOI Scopus19 WoS16 Europe PMC14 |
| 2022 |
Hillen, J., Ward, M., Slee, M., Stanford, T., Roughead, E., Kalisch Ellett, L., & Pratt, N. (2022). Utilisation of disease modifying treatment and diversity of treatment pathways in relapsing remitting multiple sclerosis. Multiple Sclerosis and Related Disorders, 57(article no. 103412), 8 pages.
DOI Scopus3 WoS3 Europe PMC3 |
| 2021 |
Park, S. H., Jeon, H. L., Kim, S. C., Hillen, J., Gadzhanova, S., Shin, J. Y., & Pratt, N. (2021). Utilization of targeted disease-modifying anti-rheumatic drugs (DMARDs) for managing rheumatoid arthritis in the last decade: A two-country comparison. International Journal of Clinical Pharmacology and Therapeutics, 59(10), 639-644.
DOI Scopus2 WoS2 Europe PMC2 |
| 2021 |
Pratt, N., Camacho, X., Vajdic, C., Degenhardt, L., Laba, T. L., Hillen, J., . . . Pearson, S. A. (2021). The Medicines Intelligence Centre of Research Excellence: Co-creating real-world evidence to support the evidentiary needs of Australian regulators and payers. International Journal of Population Data Science, 6(3), 12 pages.
DOI WoS3 |
| 2021 |
Pratt, N., Camacho, X., Vajdic, C., Degenhardt, L., Laba, T. L., Hillen, J., . . . Pearson, S. A. (2021). The Medicines Intelligence Centre of Research Excellence: Co-creating real-world evidence to support the evidentiary needs of Australian medicines regulators and payers. International Journal of Population Data Science, 6(3), 1726.
DOI Scopus3 Europe PMC3 |
| 2021 |
Hillen, J. B., Soulsby, N., & Clarke, M. (2021). Too many pills, too many sick older Australians: working together is key. Australian journal of general practice, 30(3), 171-174.
DOI Europe PMC3 |
| 2020 |
Morcos, M., Corns, J., & Hillen, J. B. (2020). Pharmacist-initiated management of a suspected case of risperidone-induced neuroleptic malignant syndrome in an aged-care resident. The role of residential medication management reviews in medication safety. Journal of Pharmacy Practice, 33(3), 382-385.
DOI |
| 2020 |
Hillen, J. B., Vitry, A., & Caughey, G. E. (2020). Erratum: Medication-related quality of care in residential aged care: an Australian experience (International Journal for Quality in Health Care (2018) (1-9) DOI: 10.1093/intqhc/mzy164). International Journal for Quality in Health Care, 32(7), 488.
DOI WoS4 Europe PMC1 |
| 2019 |
Caughey, G. E., Hillen, J. B., Bacon, S., Bullock, N., Bullock, V., & Kalisch-Ellett, L. M. (2019). Implementation of medication-related potentially preventable hospitalisation indicators in a chronic disease management program for multimorbidity.. International Journal for Quality in Health Care, 31(2), 133-139.
DOI Scopus2 WoS2 Europe PMC2 |
| 2018 |
Hillen, J. B., Vitry, A., & Caughey, G. E. (2018). Medication-related quality of care in residential aged care: an Australian experience.. International journal for quality in health care : journal of the International Society for Quality in Health Care, 31(4), 298-306.
DOI Scopus11 WoS10 Europe PMC8 |
| 2017 |
Hillen, J., Vitry, A., & Caughey, G. (2017). Disease burden, comorbidity and geriatric syndromes in the Australian aged care population. Australasian Journal on Ageing, 36(2), 14-19.
DOI Scopus38 WoS37 Europe PMC30 |
| 2017 |
Hillen, J., Vitry, A., & Caughey, G. (2017). Evaluating medication-related quality of care in Australian aged care: A role for collaborative health services. Journal of Pharmacy Practice and Research, 47(1), 63-66.
DOI Scopus3 |
| 2016 |
Hillen, J., Vitry, A., & Caughey, G. (2016). Trends in general practitioner services to residents in aged care. Australian Journal of Primary Health, 22(6), 517-522.
DOI Scopus11 WoS11 Europe PMC8 |
| 2015 |
Hillen, J., Vitry, A., & Caughey, G. (2015). Evaluating medication-related quality of care in residential aged care: a systematic review. SpringerPlus, 4(1), 17 pages.
DOI Scopus20 WoS16 Europe PMC16 |
| 2011 |
Hillen, J. B., Reed, R. L., Woodman, R. J., Law, D., Hakendorf, P. H., & Fleming, B. J. (2011). Hospital admissions from residential aged care facilities to a major public hospital in South Australia (1999-2005). Australasian Journal on Ageing, 30(4), 202-207.
DOI Scopus9 Europe PMC6 |
